Trial intelligence / Profile preview

Oseltamivir for seasonal prophylaxis of influenza in children

2006-003284-31Phase 3Terminated

Sponsor
Roche
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of oseltamivir in influenza, sponsored by Roche. Primary endpoints: Safety of seasonal prophylaxis with oseltamivir and Efficacy of oseltamivir for seasonal prophylaxis. Started Oct 2006; status: terminated.

02

Drugs

oseltamivir
03

Conditions

influenza

Beyond the preview

Go deeper on 2006-003284-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003284-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call